News | April 12, 2013

Mass General Hospital Launches Institute for Heart, Vascular and Stroke Care Building

Hospital hopes institute will redefine cardiovascular and cerebrovascular care by advancing research, education and advocacy

April 12, 2013 – The Massachusetts General Hospital officially announced the launch of the Mass General Institute for Heart, Vascular and Stroke Care, one of the only institutes in the world to integrate cardiovascular and cerebrovascular care.

The Mass General Institute for Heart, Vascular and Stroke Care delivers leading research and comprehensive clinical care to advance the diagnosis and treatment of cardiovascular and cerebrovascular disease. By matching each patient with the right specialist working in a multidisciplinary team, the Mass General Institute for Heart, Vascular and Stroke Care pioneers a patient — and disease — focused care model to provide the best possible quality of care today while discovering the medicine of tomorrow.

“Through the Institute we will continue to advance and improve the field of medicine with a cross-disciplinary team and an integrated approach to research and quality patient care,” said Michael R. Jaff, DO chair, Institute for Heart, Vascular and Stroke Care and Medical Director, Mass General Vascular Center. “Unlike others before us, the institute integrates cerebrovascular and cardiovascular care, with the goal of discovering the medicine of tomorrow and improving patient outcomes. We intend to arm medical practitioners from around the world with the latest research and tools to make positive changes in the diagnosis, treatment and care of patients.”

The Mass General Institute for Heart, Vascular and Stroke Care is built on four key pillars that include a fully integrated, personalized clinical care model, broad educational initiatives, quality and public policy advocacy leadership and robust funding programs in clinical and translational research. The institute will improve the quality and value of patient care by fully utilizing a synergistic work environment built on clinical collaboration. With this foundation, the Institute strives to achieve complete integration of clinical care and research across disciplines.

The Institute is poised to lead national and international dialogue on issues facing cardiovascular and cerebrovascular patients, and is led by a visionary team of physician-scientists who collectively serve as a trusted resource and leading voice for public policy debates.

Institute leadership includes:

  • Michael R. Jaff, DO chair, Institute for Heart, Vascular and Stroke Care and medical director, Vascular Center
  • G. William Dec, M.D., co-director, Corrigan Minehan Heart Center and chief, Cardiology Division
  • Thoralf M. Sundt, M.D., co-director, Corrigan Minehan Heart Center and chief, Cardiac Surgery
  • Lee H. Schwamm, M.D., vice chairman, Department of Neurology and director, MGH TeleStroke and Acute Stroke Services
  • Kevin Whitney, RN Aasociate chief nurse
  • Ann L. Prestipino, MPH senior vice president, Massachusetts General Hospital

 

 

The Mass General Institute for Heart, Vascular and Stroke Care has established SPARK grants to further deliver innovation and yield critical medical breakthroughs with direct funding of clinical and translational research projects. The SPARK grants are funded through a generous philanthropic gift allowing the institute to directly support the interdisciplinary projects of young and mid-career physician-scientists while bringing ground-breaking science and discovery to the forefront of the medical community.

For more information: www.massgeneral.org/institute

 

Related Content

Mobile Stroke Unit Gets Patients Quicker Treatment Than Traditional Ambulance

Image courtesy of UTHealth McGovern Medical School

News | Stroke | August 16, 2019
Every second counts for stroke patients, as studies show they can lose up to 27 million brain cells per minute....
MaxQ AI Launches Accipio Ax Slice-Level Intracranial Hemorrhage Detection
Technology | Stroke | May 21, 2019
Medical diagnostic artificial intelligence (AI) company MaxQ AI announced that Accipio Ax will begin shipping in August...
Brain images that have been pre-reviewed by the Viz.AI artificial intelligence software to identify a stroke. The software automatically sends and alert to the attending physician's smartphone with links to the imaging for a final human assessment to help speed the time to diagnosis and treatment. Depending on the type of stroke, quick action is needed to either activate the neuro-interventional lab or to administer tPA.

Brain images that have been pre-reviewed by the Viz.AI artificial intelligence software to identify a stroke. The software automatically sends and alert to the attending physician's smartphone with links to the imaging for a final human assessment to help speed the time to diagnosis and treatment. Depending on the type of stroke, quick action is needed to either activate the neuro-interventional lab or to administer tPA. Photo by Dave Fornell.

Feature | Stroke | May 17, 2019 | Inga Shugalo
With its increasing role in medical imaging, ...
Videos | Stroke | May 16, 2019
This is an example of a carotid artery reporting module from Change Healthcare at...
 UTHealth Research Finds Telemedicine Stroke Patients Receive Consistent Care 24/7
News | Stroke | April 24, 2019
Stroke patients examined remotely by a teleneurologist were treated as quickly and effectively after hours as during...
New Stroke Training Model Improves Access to Life-Saving Care
News | Stroke | March 27, 2019
Training interventional radiologists to perform endovascular thrombectomies results in positive outcomes for patients...
Gregory W. Albers, M.D., Receives Distinguished Clinical Research Achievement Award for Stroke Research
News | Stroke | March 19, 2019
iSchemaView announced the company’s co-founder Gregory Albers, M.D., has received the Distinguished Clinical Research...
Corindus Seeking Neurovascular Intervention Clearance for CorPath GRX Vascular Robotic System
News | Stroke | February 15, 2019
Corindus Vascular Robotics Inc. is seeking premarket clearance from the U.S. Food and Drug Administration (FDA) to use...
NeuroLogica and MaxQ AI Announce Distribution Agreement
News | Stroke | November 30, 2018
Clinical diagnostics intelligence platform company MaxQ AI and Samsung NeuroLogica announced a distribution agreement...
Overlay Init